Yıl: 2021 Cilt: 59 Sayı: 1 Sayfa Aralığı: 80 - 84 Metin Dili: İngilizce DOI: 10.4274/haseki.galenos.2021.6716 İndeks Tarihi: 19-06-2021

The Fate of the Gallbladder in Patients Admitted to Bariatric Surgery

Öz:
Aim: Obesity has become a rapidly increasing public health problem all over the world. Obesity itself is a risk factor for cholelithiasis, and the fast weight loss period after bariatric surgery is a situation that increases this risk. The fact that both obesity and surgical treatment of obesity increases the formation of stones in the gall bladder has made it even defendible that cholecystectomy should be performed routinely during the bariatric surgery at one stage, even if there is no cholelithiasis. In this study, we aimed to evaluate our gallbladder approach in patients who were decided to undergo bariatric surgery in our center, together with the literature reviews.Methods: In our study, the data of 185 patients who underwent bariatric surgery due to obesity in the University of Health Sciences Kanuni Sultan Suleyman the in Istanbul Training and Research Hospital Clinic of, Department of General Surgery, between 2018 and 2020 were retrospectively obtained. A total of 185 patients were included in the study. The patients were divided into group 1 (sleeve gastrectomy) and Group 2 (gastric bypass) according to their operation techniques.Results: The average age was 36.43 ± 9.52, the ratio of women/men was 151 (81.6%)/34 (18.4%). Mean body mass index (BMI) was determined as 44.16±5.09. In the postoperative period, gallstones were formed in 27 (14.6%) patients, whereas gallstones were not detected in 158 (85.4%) patients. There was no significant difference between the groups in terms of postoperative gallstone formation.Conclusion: In the light of the literature and after our clinical experience, we do not require routine imaging of the gallbladder before bariatric surgery in asymptomatic patients, and we recommend performing concomitant cholecystectomy only in symptomatic patients.
Anahtar Kelime:

Bariatrik Cerrahiye Kabul Edilen Hastalarda Safra Kesesinin Kaderi

Öz:
maç: Obezite, tüm dünyada hızla artan bir toplum sağlığı problemi haline gelmiştir. Obezitenin kendisi safra kesesi taşı oluşumu için bir risk faktörü olup, bariatrik cerrahi sonrası hızlı kilo verme dönemi de bu riski artıran bir durumdur. Hem obezitenin hem de obezitenin cerrahi tedavisinin safra kesesinde taş oluşumunu artırması, bariatrik cerrahi sırasında kesede taş olmasa bile kolesistektominin de rutin olarak yapılması gerektiğini bir dönem savunulur hale getirmiştir. Biz bu çalışmamızda merkezimizde bariatrik cerrahi kararı verilen hastalarda safra kesesi yaklaşımımızı literatür değerlendirmeleri ile beraber ele almayı amaçladık.Yöntemler: Çalışmamızda 2018-2020 yılları arasında İstanbul Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi Genel Cerrahi Kliniği’nde obezite nedeni ile bariatrik cerrahi operasyonu geçiren toplan 185 hastanın bilgileri retrospektif olarak değerlendirildi. Çalışmaya toplam 185 hasta dahil edildi. Hastalar operasyon tekniklerine göre grup 1 (sleeve gastrektomi) ve grup 2 (gastrik bypass) olacak şekilde ayrıldı. Bulgular: Yaş ortalaması 36,43±9,52 yıl, kadın/erkek oranı ise 151 (%81,6)/34 (%18,4) idi. Ortalama vücut kitle indeksi (VKİ) 44,16±5,09 olarak tespit edildi. Postoperatif dönemde 27 (%14,6) hastada safra kesesi taşı oluşurken, 158 (%85,4) hastada safra kesesinde taş tespit edilmedi. Gruplar arasında postoperatif safra kesesi taşı oluşumu açısından anlamlı fark yoktu. Sonuç: Literatür ışığında ve klinik tecrübelerimiz sonrası, bariatrik cerrahi öncesi safra kesesi görüntülemesinin asemptomatik hastalarda rutin yapılmasını gerek görmemekte, sadece semptomatik hastalarda eşzamanlı kolesistektomi yapılmasını önermekteyiz.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1.Doulamis IP, Economopoulos KP. Transumbilical Roux-en-Y gastric bypass in morbidly obese patients: A systematic review. Int J Surg 2015;20:153-7.
  • 2.Varela JE. Laparoscopic sleeve gastrectomy versus laparoscopic adjustable gastric banding for the treatment severe obesity in high risk patients. JSLS 2011;15:486-91.
  • 3.Villegas L, Schneider B, Provost D, et al. Is routine cholecystectomy required during laparoscopic gastric bypass? Obes Surg 2004;14:206-11.
  • 4.Leyva-Alvizo A, Arredondo-Saldaña G, Leal-Isla-Flores V, et al. Systematic review of management of gallbladder disease in patients undergoing minimally invasive bariatric surgery. Surg Obes Relat Dis 2020;16:158-64.
  • 5.Fobi M, Lee H, Igwe D, et al. Prophylactic cholecystectomy with gastric bypass operation: incidence of gallbladder disease. Obes Surg 2002;12:350-3.
  • 6.Njeze GE. Gallstones. Niger J Surg 2013;19:49-55.
  • 7.Johnston DE, Kaplan MM. Pathogenesis and treatment of gallstones. N Engl J Med 1993;328:412-21.
  • 8.Nagem R, Lázaro-da-Silva A. Cholecystolithiasis after gastric bypass: a clinical, biochemical, and ultrasonographic 3-year follow-up study. Obes Surg 2012;22:1594-9.
  • 9.Escalona A, Boza C, Muñoz R, et al. Routine preoperative ultrasonography and selective cholecystectomy in laparoscopic Roux-en-Y gastric bypass. Why not? Obes Surg 2008;18:47-51.
  • 10. Jonas E, Marsk R, Rasmussen F, Freedman J. Incidence of postoperative gallstone disease after antiobesity surgery: population-based study from Sweden. Surg Obes Relat Dis 2010;6:54-8.
  • 11.Uy MC, Talingdan-Te MC, Espinosa WZ, Daez ML, Ong JP. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis. Obes Surg 2008;18:1532-8.
  • 12.Iglézias Brandão de Oliveira C, Adami Chaim E, da Silva BB. Impact of rapid weight reduction on risk of cholelithiasis after bariatric surgery. Obes Surg 2003;13:625-8.
  • 13.Tustumi F, Bernardo WM, Santo MA, Cecconello I. Cholecystectomy in Patients Submitted to Bariatric Procedure: A Systematic Review and Meta-analysis. Obes Surg 2018;28:3312-20.
  • 14.Abdallah E, Emile SH, Elfeki H, et al. Role of ursodeoxycholic acid in the prevention of gallstone formation after laparoscopic sleeve gastrectomy. Surg Today 2017;47:844-50.
  • 15.Coupaye M, Calabrese D, Sami O, Msika S, Ledoux S. Evaluation of incidence of cholelithiasis after bariatric surgery in subjects treated or not treated with ursodeoxycholic acid. Surg Obes Relat Dis 2017;13:681-85.
  • 16. Coupaye M, Castel B, Sami O, Tuyeras G, Msika S, Ledoux S. Comparison of the incidence of cholelithiasis after sleeve gastrectomy and Roux-en-Y gastric bypass in obese patients: a prospective study. Surg Obes Relat Dis 2015;11:779-84.
  • 17.Stokes CS, Gluud LL, Casper M, Lammert F. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol 2014;12:1090-100.
  • 18.Sugerman HJ, Brewer WH, Shiffman ML, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg 1995;169:91-6; discussion 96-7.
  • 19.Sakorafas GH, Milingos D, Peros G. Asymptomatic cholelithiasis: is cholecystectomy really needed? A critical reappraisal 15 years after the introduction of laparoscopic cholecystectomy. Dig Dis Sci 2007;52:1313-25.
  • 20.Patel JA, Patel NA, Piper GL, Smith DE 3rd, Malhotra G, Colella JJ. Perioperative management of cholelithiasis in patients presenting for laparoscopic Roux-en-Y gastric bypass: have we reached a consensus? Am Surg 2009;75:470-6; discussion 476.
  • 21.Shiffman ML, Sugerman HJ, Kellum JM, Brewer WH, Moore EW. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 1991;86:1000-5.
  • 22.D’Hondt M, Sergeant G, Deylgat B, Devriendt D, Van Rooy F, Vansteenkiste F. Prophylactic cholecystectomy, a mandatory step in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass? J Gastrointest Surg 2011;15:1532-6.
  • 23.Dakour-Aridi HN, El-Rayess HM, Abou-Abbass H, Abu-Gheida I, Habib RH, Safadi BY. Safety of concomitant cholecystectomy at the time of laparoscopic sleeve gastrectomy: analysis of the American College of Surgeons National Surgical Quality Improvement Program database. Surg Obes Relat Dis 2017;13:934-41.
  • 24.Doulamis IP, Michalopoulos G, Boikou V, et al. Concomitant cholecystectomy during bariatric surgery: The jury is still out. Am J Surg 2019;218:401-10.
  • 25.Altieri MS, Yang J, Nie L, Docimo S, Talamini M, Pryor AD. Incidence of cholecystectomy after bariatric surgery. Surg Obes Relat Dis 2018;14:992-6.
  • 26.Ruiz-Tovar J, Boix E, Galindo I, et al. Evolution of subclinical hypothyroidism and its relation with glucose and triglycerides levels in morbidly obese patients after undergoing sleeve gastrectomy as bariatric procedure. Obes Surg 2014;24:791-5.
  • 27.Abelson JS, Afaneh C, Dolan P, Chartrand G, Dakin G, Pomp A. Laparoscopic Sleeve Gastrectomy: Co-morbidity Profiles and Intermediate-Term Outcomes. Obes Surg 2016;26:1788-93.
  • 28.Golomb I, Ben David M, Glass A, Kolitz T, Keidar A. Long-term Metabolic Effects of Laparoscopic Sleeve Gastrectomy. JAMA Surg 2015;150:1051-7.
  • 29.Matlaga BR, Shore AD, Magnuson T, Clark JM, Johns R, Makary MA. Effect of gastric bypass surgery on kidney stone disease. J Urol 2009;181:2573-7.
APA KIZILKAYA M, YILMAZ S (2021). The Fate of the Gallbladder in Patients Admitted to Bariatric Surgery. , 80 - 84. 10.4274/haseki.galenos.2021.6716
Chicago KIZILKAYA Mehmet Celal,YILMAZ SERHAN The Fate of the Gallbladder in Patients Admitted to Bariatric Surgery. (2021): 80 - 84. 10.4274/haseki.galenos.2021.6716
MLA KIZILKAYA Mehmet Celal,YILMAZ SERHAN The Fate of the Gallbladder in Patients Admitted to Bariatric Surgery. , 2021, ss.80 - 84. 10.4274/haseki.galenos.2021.6716
AMA KIZILKAYA M,YILMAZ S The Fate of the Gallbladder in Patients Admitted to Bariatric Surgery. . 2021; 80 - 84. 10.4274/haseki.galenos.2021.6716
Vancouver KIZILKAYA M,YILMAZ S The Fate of the Gallbladder in Patients Admitted to Bariatric Surgery. . 2021; 80 - 84. 10.4274/haseki.galenos.2021.6716
IEEE KIZILKAYA M,YILMAZ S "The Fate of the Gallbladder in Patients Admitted to Bariatric Surgery." , ss.80 - 84, 2021. 10.4274/haseki.galenos.2021.6716
ISNAD KIZILKAYA, Mehmet Celal - YILMAZ, SERHAN. "The Fate of the Gallbladder in Patients Admitted to Bariatric Surgery". (2021), 80-84. https://doi.org/10.4274/haseki.galenos.2021.6716
APA KIZILKAYA M, YILMAZ S (2021). The Fate of the Gallbladder in Patients Admitted to Bariatric Surgery. Haseki Tıp Bülteni, 59(1), 80 - 84. 10.4274/haseki.galenos.2021.6716
Chicago KIZILKAYA Mehmet Celal,YILMAZ SERHAN The Fate of the Gallbladder in Patients Admitted to Bariatric Surgery. Haseki Tıp Bülteni 59, no.1 (2021): 80 - 84. 10.4274/haseki.galenos.2021.6716
MLA KIZILKAYA Mehmet Celal,YILMAZ SERHAN The Fate of the Gallbladder in Patients Admitted to Bariatric Surgery. Haseki Tıp Bülteni, vol.59, no.1, 2021, ss.80 - 84. 10.4274/haseki.galenos.2021.6716
AMA KIZILKAYA M,YILMAZ S The Fate of the Gallbladder in Patients Admitted to Bariatric Surgery. Haseki Tıp Bülteni. 2021; 59(1): 80 - 84. 10.4274/haseki.galenos.2021.6716
Vancouver KIZILKAYA M,YILMAZ S The Fate of the Gallbladder in Patients Admitted to Bariatric Surgery. Haseki Tıp Bülteni. 2021; 59(1): 80 - 84. 10.4274/haseki.galenos.2021.6716
IEEE KIZILKAYA M,YILMAZ S "The Fate of the Gallbladder in Patients Admitted to Bariatric Surgery." Haseki Tıp Bülteni, 59, ss.80 - 84, 2021. 10.4274/haseki.galenos.2021.6716
ISNAD KIZILKAYA, Mehmet Celal - YILMAZ, SERHAN. "The Fate of the Gallbladder in Patients Admitted to Bariatric Surgery". Haseki Tıp Bülteni 59/1 (2021), 80-84. https://doi.org/10.4274/haseki.galenos.2021.6716